Spectrum of Clinical Manifestations among Paediatrics and Adult Patients of Idiopathic Thrombocytopenic Purpura Presenting to Tertiary Care Hospital

Clinical Manifestations of Thrombocytopenic Purpura

Authors

  • Masuma Ghazanfar Department of Pathology, Allama Iqbal Medical College, Lahore, Pakistan
  • Hamid Sarwar Department of Pathology, Allama Iqbal Medical College, Lahore, Pakistan
  • Muhammad Hassan Cheema Department of Pathology, Sahara Medical College, Lahore, Pakistan
  • Muhammad Hussnain Cheema Department of Pathology, Sahara Medical College, Lahore, Pakistan
  • Noor Fatima Department of Medicine, District Health Quarter, Layyah, Pakistan
  • Ali Husnain Sheikh Department of Ear, Nose and Throat, Akhtar Saeed Medical College, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i05.1574

Keywords:

Thrombocytopenic Purpura, Autoimmune Disorder, Menorrhagia, Bruises

Abstract

Idiopathic Thrombocytopenia Purpura (ITP), an autoimmune bleeding disorder, affects both children and adults, categorized into acute, persistent or chronic types based on symptom duration. Clinical presentations vary widely, ranging from minor bleeds to severe systemic hemorrhages involving CNS, GIT and genitourinary tract. Objective: To assess clinical manifestations in ITP patients at a Lahore tertiary care Hematology department. Methods: This retrospective cross-sectional study included data from 660 diagnosed ITP patients from January 2020 to December 2022 using consecutive sampling technique at Allama Iqbal Medical College. Data were recorded after taking consent from patients. Results: Mean age was 31.8 ± 12.8 SD, with 10.3% children and 89.7% adults. Patients were categorized based on platelet counts into mild, moderate, and severe groups. Most children (47%) and adults (59.9%) had moderate thrombocytopenia. Common features included bruising in children (67.6%), gum bleeding (77%) in adults of both sexes and menorrhagia (67.9%) in females. Conclusions: ITP affects all ages but predominantly females. Clinical presentation varies, with most cases showing superficial bleeding like bruising, epistaxis, gum bleeding, or menorrhagia in females.

References

Champatiray J, Behera DK, Krishnamoorthy A, Bhat S. Evaluation of prevalence, clinical spectrum and outcome of acute ITP in children in a tertiary care centre in Odisha, India. International Journal of Contemporary Pediatrics. 2017 Jul; 4(4): 1470-5. doi: 10.18203/2349-3291.ijcp20172688. DOI: https://doi.org/10.18203/2349-3291.ijcp20172688

Ejaz A and Radia D. Diagnosis and management of primary immune thrombocytopenia in adults. British Journal of Hospital Medicine. 2019 Apr; 80(4): C54-7. doi: 10.12968/hmed.2019.80.4.C54. DOI: https://doi.org/10.12968/hmed.2019.80.4.C54

Cooper N. State of the art-how I manage immune thrombocytopenia. British Journal of Haematology. 2017 Apr; 177(1): 39-54. doi: 10.1111/bjh.14515. DOI: https://doi.org/10.1111/bjh.14515

Rashid N, Imtiaz U, Iqbal I, Malik A, Khalid A, Mobeen S. Spectrum of skin manifestations in patients presenting with idiopathic thrombocytopenic purpura in a tertiary care hospital. Journal of Pakistan Association of Dermatologists. 2020 Sep; 30(2): 286-8.

Pamuk G, Pamuk Ö, Başlar Z, Öngören Ş, Soysal T, Ferhanoğlu B et al. Overview of 321 patients with idiopathic thrombocytopenic purpura: retrospective analysis of the clinical features and response to therapy. Annals of Hematology. 2002 Aug; 81: 436-40. doi: 10.1007/s00277-002-0488-x. DOI: https://doi.org/10.1007/s00277-002-0488-x

Farid J, Gul N, Idris M. Clinical presentations in immune thrombocytopenic purpura. Journal of Ayub Medical College Abbottabad. 2012 Jun; 24(2): 39-40.

Chakrabarti P, George B, Shanmukhaiah C, Sharma LM, Udupi S, Ghanima W. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh). Journal of Patient Reported Outcomes. 2022 Mar; 6(1): 24. doi: 10.1186/s41687-022-00429-y. DOI: https://doi.org/10.1186/s41687-022-00429-y

Hassan A, Adebayo A, Musa AU, Suleiman AM, Ibrahim IN, Kusfa IU et al. Clinical feature and management of immune thrombocytopenic purpura in a tertiary hospital in Northwest Nigeria. Nigerian Medical Journal. 2017 Mar; 58(2): 68-71. doi: 10.4103/0300-1652.219343. DOI: https://doi.org/10.4103/0300-1652.219343

Godhani UR and Devaliya JJ. Clinical profile of patients with thrombocytopenia attending a tertiary care hospital, Gujarat. Scholars Journal of Applied Medical Sciences. 2016 Aug; 4(8E): 3058-62. doi: 10.36347/sjams.2016.v04i08.063.

Shah HR, Vaghani BD, Gohel P, Virani BK. Clinical profile review of patients with thrombocytopenia: A study of 100 cases at a tertiary care centre. International Journal of Current Research and Review. 2015 Mar; 7(6): 33.

Alwadi KW, Alomari A, Alrugaib AK, Alrubayea A, Alzoman M, Alkahtani F. Clinical Characteristics and Outcomes of Pediatric Patients With Immune Thrombocytopenic Purpura in King Abdulaziz Medical City and King Abdullah Specialist Children's Hospital: A 10-Year Study. Cureus. 2020 Nov; 12(11): e11366. doi: 10.7759/cureus.11366. DOI: https://doi.org/10.7759/cureus.11366

Thiagarajan S and Omana S. Clinical profile of immune thrombocytopenic purpua and outcome at 6 months: a South Indian observational study. International Journal of Contemporary Pediatrics. 2018 Jan; 5(1): 190. doi: 10.18203/2349-3291.ijcp20175584. DOI: https://doi.org/10.18203/2349-3291.ijcp20175584

Rashid N, Imtiaz U, Iqbal I. Spectrum of skin manifestations in patients presenting with idiopathic thrombocytopenic purpura in a tertiary care hospital. Journal of Pakistan Association of Dermatologists. 2020; 30(2): 286-8.

Zimmer J, Andres E, Noel E, Koumarianou A, Blicklé JF, Maloisel F. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center 1. Clinical & Laboratory Haematology. 2004 Apr; 26(2): 137-42. doi: 10.1111/j.1365-2257.2004.00591.x. DOI: https://doi.org/10.1111/j.1365-2257.2004.00591.x

George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul; 88(1): 3-40. doi: 10.1182/blood.V88.1.3.3. DOI: https://doi.org/10.1182/blood.V88.1.3.3

Cines DB and Blanchette VS. Immune thrombocytopenic purpura. New England Journal of Medicine. 2002 Mar; 346(13): 995-1008. doi: 10.1056/NEJMra010501. DOI: https://doi.org/10.1056/NEJMra010501

Bussel J. Treatment of immune thrombocytopenic purpura in adults. InSeminars in Hematology. 2006 Jul; 43: S3-S10. doi: 10.1053/j.seminhematol.2006.04.009. DOI: https://doi.org/10.1053/j.seminhematol.2006.04.009

Chong BH and Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. InSeminars in Hematology. 2000 Jul; 37(3): 249-260. doi: 10.1053/shem.2000.8956. DOI: https://doi.org/10.1053/shem.2000.8956

Cohen R, Garcia CA, Mena D, Castellanos M. Case review: idiopathic thrombocytopenic purpura. Journal of Medical Cases. 2012 Mar; 3(2): 130-4. doi: 10.4021/jmc506w. DOI: https://doi.org/10.4021/jmc506w

McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. InSeminars in Hematology. 2000 Jul; 37(3): 239-248. doi: 10.1016/S0037-1963(00)90102-1. DOI: https://doi.org/10.1016/S0037-1963(00)90102-1

Downloads

Published

2024-05-31
CITATION
DOI: 10.54393/pjhs.v5i05.1574
Published: 2024-05-31

How to Cite

Ghazanfar, M., Sarwar, H., Cheema, M. H., Cheema, M. H., Fatima, N., & Sheikh, A. . H. (2024). Spectrum of Clinical Manifestations among Paediatrics and Adult Patients of Idiopathic Thrombocytopenic Purpura Presenting to Tertiary Care Hospital: Clinical Manifestations of Thrombocytopenic Purpura. Pakistan Journal of Health Sciences, 5(05), 138–141. https://doi.org/10.54393/pjhs.v5i05.1574

Issue

Section

Original Article

Plaudit